CD44 isoforms in normal and leukemic hematopoiesis

Experimental Hematology

Volumn 27, Issue 6, 1999, Pages 978-993

  Ghaffari, Saghi ^a   Smadja Joffe, Florence ^b   Oostendorp, Robert ^a,c   Lévesque, Jean Pierre ^d   Dougherty, Graeme ^e   Eaves, Allen ^a   Eaves, Connie ^a  

^a BRITISH COLUMBIA CANCER AGENCY   (Canada)

^b HÔPITAL PAUL BROUSSE   (France)

^c INSTITUTE OF EPIDEMIOLOGY   (Germany)

^d Matthew Roberts Laboratory   (Australia)

^e UCLA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HERMES ANTIGEN; MONOCLONAL ANTIBODY;

ACUTE GRANULOCYTIC LEUKEMIA; ANIMAL CELL; ANTIGEN EXPRESSION; CHRONIC MYELOID LEUKEMIA; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL; LEUKEMIA; LEUKEMIA CELL; LIGAND BINDING; MOUSE; NONHUMAN; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; ANTIGENS, CD44; HEMATOPOIESIS; HEMATOPOIETIC STEM CELLS; HUMANS; LEUKEMIA; MICE; MICE, KNOCKOUT; SIGNAL TRANSDUCTION;

EID: 0033033065     PISSN: 0301472X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0301-472X(99)00023-5     Document Type: Review

References (184)

1. Lesley J., Hyman R., Kincade P.W. CD44 and its interaction with extracellular matrix. Adv Immunol. 54:1993;271-335.
2. Screaton G.R., Bell M.V., Jackson D.G., Cornelis F.B., Gerth U., Bell J.I. Genomic structure of DNA encoding the lymphocyte homing receptor CD44 reveals at least 12 alternatively spliced exons. Proc Natl Acad Sci U S A. 89:1992;12160-12164.
3. Tolg C., Hofmann M., Herrlich P., Ponta H. Splicing choice from ten variant exons establishes CD44 variability. Nucleic Acids Res. 21:1993;1225-1229.
4. Goodfellow P.N., Banting G., Wiles M.V., Tunnacliffe A., Parkar M., Solomon E., Dalchau R., Fabre J.W. The gene, MIC4, which controls expression of the antigen defined by monoclonal antibody F10.44.2, is on human chromosome 11. Eur J Immunol. 12:1982;659-663.
5. Francke U., Foellmer B.E., Haynes B.F. Chromosome mapping of human cell surface molecules. monoclonal anti-human lymphocyte antibodies 4F2, A3D8, and A1G3 define antigens controlled by different regions of chromosome 11 Somatic Cell Genet. 9:1983;333-344.
6. Zhou D.F., Ding J.F., Picker L.J., Bargatze R.F., Butcher E.C., Goeddel D.V. Molecular cloning and expression of Pgp-1. The mouse homolog of the human H-CAM (Hermes) lymphocyte homing receptor. J Immunol. 143:1989;3390-3395.
7. Nottenburg C., Rees G., St. John T. Isolation of mouse CD44 cDNA. structural features are distinct from the primate cDNA Proc Natl Acad Sci U S A. 86:1989;8521-8525.
8. Stamenkovic I., Amiot M., Pesando J.M., Seed B. A lymphocyte molecule implicated in lymph node homing is a member of the cartilage link protein family. Cell. 56:1989;1057-1062.
9. Goldstein L.A., Zhou D.F., Picker L.J., Minty C.N., Bargatze R.F., Ding J.F., Butcher E.C. A human lymphocyte homing receptor, the hermes antigen, is related to cartilage proteoglycan core and link proteins. Cell. 56:1989;1063-1072.
10. Goldstein L.A., Butcher E.C. Identification of mRNA that encodes an alternative form of H-CAM(CD44) in lymphoid and nonlymphoid tissues. Immunogenetics. 32:1990;389-397.
11. Dougherty G.J., Landorp P.M., Cooper D.L., Humphries R.K. Molecular cloning of CD44R1 and CD44R2, two novel isoforms of the human CD44 lymphocyte "homing" receptor expressed by hemopoietic cells. J Experimental Med. 174:1991;1-5.
12. Hofmann M., Rudy W., Zoller M., Tolg C., Ponta H., Herrlich P., Gunthert U. CD44 splice variants confer metastatic behavior in rats. homologous sequences are expressed in human tumor cell lines Cancer Res. 51:1991;5292-5297.
13. Stamenkovic I., Aruffo A., Amiot M., Seed B. The hematopoietic and epithelial forms of CD44 are distinct polypeptides with different adhesion potentials for hyaluronate-bearing cells. EMBO J. 10:1991;343-348.
14. Jackson D.G., Buckley J., Bell J.I. Multiple variants of the human lymphocyte homing receptor CD44 generated by insertions at a single site in the extracellular domain. J Biol Chem. 267:1992;4732-4739.
15. Brown T.A., Bouchard T., St. John T., Wayner E., Carter W.G. Human keratinocytes express a new CD44 core protein (CD44E) as a heparan-sulfate intrinsic membrane proteoglycan with additional exons. J Cell Biol. 113:1991;207-221.
16. Jalkanen S., Bargatze R.F., de los Toyos J., Butcher E.C. Lymphocyte recognition of high endothelium. antibodies to distinct epitopes of an 85-95-kD glycoprotein antigen differentially inhibit lymphocyte binding to lymph node, mucosal, or synovial endothelial cells J Cell Biol. 105:1987;983-990.
17. Underhill C.B., Green S.J., Comoglio P.M., Tarone G. The hyaluronate receptor is identical to a glycoprotein of Mr 85,000 (gp85) as shown by a monoclonal antibody that interferes with binding activity. J Biol Chem. 262:1987;13142-13146.
18. Wayner E.A., Carter W.G. Identification of multiple cell adhesion receptors for collagen and fibronectin in human fibrosarcoma cells possessing unique alpha and common beta subunits. J Cell Biol. 105:1987;1873-1884.
19. Carter W.G., Wayner E.A. Characterization of the class III collagen receptor, a phosphorylated, transmembrane glycoprotein expressed in nucleated human cells. J Biol Chem. 263:1988;4193-4201.
20. Jalkanen S., Jalkanen M., Bargatze R., Tammi M., Butcher E.C. Biochemical properties of glycoproteins involved in lymphocyte recognition of high endothelial venules in man. J Immunol. 141:1988;1615-1623.
21. Kansas G.S., Wood G.S., Dailey M.O. A family of cell-surface glycoproteins defined by a putative anti-endothelial cell receptor antibody in man. J Immunol. 142:1989;3050-3057.
22. Naujokas M.F., Morin M., Anderson M.S., Peterson M., Miller J. The chondroitin sulfate form of invariant chain can enhance stimulation of T cell responses through interaction with CD44. Cell. 74:1993;257-268.
23. Picker L.J., De los Toyos J., Telen M.J., Haynes B.F., Butcher E.C. Monoclonal antibodies against the CD44 [In(Lu)-related p80], and Pgp-1 antigens in man recognize the Hermes class of lymphocyte homing receptors. J Immunol. 142:1989;2046-2051.
24. Bazil V., Horejsi V. Shedding of the CD44 adhesion molecule from leukocytes induced by anti-CD44 monoclonal antibody simulating the effect of a natural receptor ligand. J Immunol. 149:1992;747-753.
25. Yang H., Binns R.M. Isolation and characterization of the soluble and membrane-bound porcine CD44 molecules. Immunology. 78:1993;547-554.
26. Katoh S., McCarthy J.B., Kincade P.W. Characterization of soluble CD44 in the circulation of mice. Levels are affected by immune activity and tumor growth. J Immunol. 153:1994;3440-3449.
27. Ristamaki R., Joensuu H., Salmi M., Jalkanen S. Serum CD44 in malignant lymphoma. an association with treatment response Blood. 84:1994;238-243.
28. Kohda D., Morton C.J., Parkar A.A., Hatanaka H., Inagaki F.M., Campbell I.D., Day A.J. Solution structure of the link module. a hyaluronan-binding domain involved in extracellular matrix stability and cell migration Cell. 86:1996;767-775.
29. Culty M., Miyake K., Kincade P.W., Sikorski E., Butcher E.C., Underhill C., Sikorski E. The hyaluronate receptor is a member of the CD44 (H-CAM) family of cell surface glycoproteins [published erratum appears in J Cell Biol (1991) 112(3):following 513]. J Cell Biol. 111:1990;2765-2774.
30. Aruffo A., Stamenkovic I., Melnick M., Underhill C.B., Seed B. CD44 is the principal cell surface receptor for hyaluronate. Cell. 61:1990;1303-1313.
31. Jalkanen S., Aho R., Kallajoki M., Ekfors T., Nortamo P., Gahmberg C., Duijvestijn A., Kalimo H. Lymphocyte homing receptors and adhesion molecules in intravascular malignant lymphomatosis. International J Cancer. 44:1989;777-782.
32. Spring F.A., Dalchau R., Daniels G.L., Mallinson G., Judson P.A., Parsons S.F., Fabre J.W., Anstee D.J. The Ina and Inb blood group antigens are located on a glycoprotein of 80,000 MW (the CDw44 glycoprotein) whose expression is influenced by the In(Lu) gene. Immunology. 64:1988;37-43.
33. Miyake K., Underhill C.B., Lesley J., Kincade P.W. Hyaluronate can function as a cell adhesion molecule and CD44 participates in hyaluronate recognition. J Exp Med. 172:1990;69-75.
34. Miyake K., Medina K.L., Hayashi S., Ono S., Hamaoka T., Kincade P.W. Monoclonal antibodies to Pgp-1/CD44 block lympho-hemopoiesis in long-term bone marrow cultures. J Exp Med. 171:1990;477-488.
35. Peach R.J., Hollenbaugh D., Stamenkovic I., Aruffo A. Identification of hyaluronic acid binding sites in the extracellular domain of CD44. J Cell Biol. 122:1993;257-264.
36. Yang B., Yang B.L., Savani R.C., Turley E.A. Identification of a common hyaluronan binding motif in the hyaluronan binding proteins RHAMM, CD44 and link protein. EMBO J. 13:1994;286-296.
37. He Q., Lesley J., Hyman R., Ishihara K., Kincade P.W. Molecular isoforms of murine CD44 and evidence that the membrane proximal domain is not critical for hyaluronate recognition. J Cell Biol. 119:1992;1711-1719.
38. Dougherty G.J., Cooper D.L., Memory J.F., Chiu R.K. Ligand binding specificity of alternatively spliced CD44 isoforms. Recognition and binding of hyaluronan by CD. 44R1.(J Biol Chem 269):1994;9074-9078.
39. Bennett K.L., Modrell B., Greenfield B., Bartolazzi A., Stamenkovic I., Peach R., Jackson D.G., Spring F., Aruffo A. Regulation of CD44 binding to hyaluronan by glycosylation of variably spliced exons. J Cell Biol. 131:1995;1623-1633.
40. Lesley J., English N., Perschl A., Gregoroff J., Hyman R. Variant cell lines selected for alterations in the function of the hyaluronan receptor CD44 show differences in glycosylation. J Exp Med. 182:1995;431-437.
41. Katoh S., Zheng Z., Oritani K., Shimozato T., Kincade P.W. Glycosylation of CD44 negatively regulates its recognition of hyaluronan. J Exp Med. 182:1995;419-429.
42. Lesley J., Kincade P.W., Hyman R. Antibody-induced activation of the hyaluronan receptor function of CD44 requires multivalent binding by antibody. Eur J Immunol. 23:1993;1902-1909.
43. Faassen A.E., Schrager J.A., Klein D.J., Oegema T.R., Couchman J.R., McCarthy J.B. A cell surface chondroitin sulfate proteoglycan, immunologically related to CD44, is involved in type I collagen-mediated melanoma cell motility and invasion. J Cell Biol. 116:1992;521-531.
44. Jalkanen S., Jalkanen M. Lymphocyte CD44 binds the COOH-terminal heparin-binding domain of fibronectin. J Cell Biol. 116:1992;817-825.
45. Streeter P.R., Berg E.L., Rouse B.T., Bargatze R.F., Butcher E.C. A tissue-specific endothelial cell molecule involved in lymphocyte homing. Nature. 331:1988;41-46.
46. Droll A., Dougherty S.T., Chiu R.K., Dirks J.F., McBride W.H., Cooper D.L., Dougherty G.J. Adhesive interactions between alternatively spliced CD44 isoforms. J Biol Chem. 270:1995;11567-11573.
47. St. John T., Meyer J., Idzerda R., Gallatin W.M. Expression of CD44 confers a new adhesive phenotype on transfected cells. Cell. 60:1990;45-52.
48. Koopman G., van Kooyk Y., de Graaff M., Meyer C.J., Figdor C.G., Pals S.T. Triggering of the CD44 antigen on T lymphocytes promotes T cell adhesion through the LFA-1 pathway. J Immunol. 145:1990;3589-3593.
49. Belitsos P.C., Hildreth J.E., August J.T. Homotypic cell aggregation induced by anti-CD44(Pgp-1) monoclonal antibodies and related to CD44(Pgp-1) expression. J Immunol. 144:1990;1661-1670.
50. Lesley J., Schulte R., Hyman R. Binding of hyaluronic acid to lymphoid cell lines is inhibited by monoclonal antibodies against Pgp-1. Exp Cell Res. 187:1990;224-233.
51. Toyama-Sorimachi N., Miyasaka M. A sulfated proteoglycan as a novel ligand for CD44. J Dermatol. 21:1994;795-801.
52. Stevens R.L., Avraham S., Gartner M.C., Bruns G.A., Austen K.F., Weis J.H. Isolation and characterization of a cDNA that encodes the peptide core of the secretory granule proteoglycan of human promyelocytic leukemia HL-60 cells. J Biol Chem. 263:1988;7287-7291.
53. Toyama-Sorimachi N., Sorimachi H., Tobita Y., Kitamura F., Yagita H., Suzuki K., Miyasaka M. A novel ligand for CD44 is serglycin, a hematopoietic cell lineage-specific proteoglycan. Possible involvement in lymphoid cell adherence and activation. J Biol Chem. 270:1995;7437-7444.
54. Weber G.F., Ashkar S., Glimcher M.J., Cantor H. Receptor-ligand interaction between CD44 and osteopontin (Eta-1). Science. 271:1996;509-512.
55. Weber G.F., Ashkar S., Cantor H. Interaction between CD44 and osteopontin as a potential basis for metastasis formation. Proc Assoc Am Physicians. 109:1997;1-9.
56. Patarca R., Wei F.Y., Singh P., Morasso M.I., Cantor H. Dysregulated expression of the T cell cytokine Eta-1 in CD4-8- lymphocytes during the development of murine autoimmune disease. J Exp Med. 172:1990;1177-1183.
57. Smith L.L., Cheung H.K., Ling L.E., Chen J., Sheppard D., Pytela R., Giachelli C.M. Osteopontin N-terminal domain contains a cryptic adhesive sequence recognized by alpha9beta1 integrin. J Biol Chem. 271:1996;28485-28491.
58. Lacy B.E., Underhill C.B. The hyaluronate receptor is associated with actin filaments. J Cell Biol. 105:1987;1395-1404.
59. Kalomiris E.L., Bourguignon L.Y. Mouse T lymphoma cells contain a transmembrane glycoprotein (GP85) that binds ankyrin. J Cell Biol. 106:1988;319-327.
60. Tsukita S., Oishi K., Sato N., Sagara J., Kawai A., Tsukita S. ERM family members as molecular linkers between the cell surface glycoprotein CD44 and actin-based cytoskeletons. J Cell Biol. 126:1994;391-401.
61. Taher T.E., Smit L., Griffioen A.W., Schilder-Tol E.J., Borst J., Pals S.T. Signaling through CD44 is mediated by tyrosine kinases. Association with p. 56lck(in T lymphocytes. J Biol Chem 271):1996;2863-2867.
62. Ilangumaran S., Briol A., Hoessli D.C. CD44 selectively associates with active Src family protein tyrosine kinases Lck and Fyn in glycosphingolipid-rich plasma membrane domains of human peripheral blood lymphocytes. Blood. 91:1998;3901-3908.
63. Lokeshwar V.B., Bourguignon L.Y. The lymphoma transmembrane glycoprotein GP85 (CD44) is a novel guanine nucleotide-binding protein which regulates GP85 (CD44)-ankyrin interaction. J Biol Chem. 267:1992;22073-22078.
64. Lesley J., He Q., Miyake K., Hamann A., Hyman R., Kincade P.W. Requirements for hyaluronic acid binding by CD44. a role for the cytoplasmic domain and activation by antibody J Exp Med. 175:1992;257-266.
65. Lokeshwar V.B., Fregien N., Bourguignon L.Y. Ankyrin-binding domain of CD44(GP85) is required for the expression of hyaluronic acid-mediated adhesion function. J Cell Biol. 126:1994;1099-1109.
66. Thomas L., Byers H.R., Vink J., Stamenkovic I. CD44H regulates tumor cell migration on hyaluronate-coated substrate. J Cell Biol. 118:1992;971-977.
67. Hathcock K.S., Hirano H., Murakami S., Hodes R.J. CD44 expression on activated B cells. Differential capacity for CD. 44-dependent(binding to hyaluronic acid. J Immunol 151):1993;6712-6722.
68. Perschl A., Lesley J., English N., Trowbridge I., Hyman R. Role of CD44 cytoplasmic domain in hyaluronan binding. Eur J Immunol. 25:1995;495-501.
69. Kalomiris E.L., Bourguignon L.Y. Lymphoma protein kinase C is associated with the transmembrane glycoprotein, GP85, and may function in GP85-ankyrin binding. J Biol Chem. 264:1989;8113-8119.
70. Camp R.L., Kraus T.A., Pure E. Variations in the cytoskeletal interaction and posttranslational modification of the CD44 homing receptor in macrophages. J Cell Biol. 115:1991;1283-1292.
71. Neame S.J., Isacke C.M. The cytoplasmic tail of CD44 is required for basolateral localization in epithelial MDCK cells but does not mediate association with the detergent-insoluble cytoskeleton of fibroblasts. J Cell Biol. 121:1993;1299-1310.
72. Neame S.J., Isacke C.M. Phosphorylation of CD44 in vivo requires both Ser323 and Ser325, but does not regulate membrane localization or cytoskeletal interaction in epithelial cells. EMBO J. 11:1992;4733-4738.
73. Hyman R., Lesley J., Schulte R. Somatic cell mutants distinguish CD44 expression and hyaluronic acid binding. Immunogenetics. 33:1991;392-395.
74. Murakami S., Shimabukuro Y., Miki Y., Saho T., Hino E., Kasai D., Nozaki T., Kusumoto Y., Okada H. Inducible binding of human lymphocytes to hyaluronate via CD44 does not require cytoskeleton association but does require new protein synthesis. J Immunol. 152:1994;467-477.
75. Morimoto K., Robin E., Le Bousse-Kerdiles M.C., Li Y., Clay D., Jasmin C., Smadja-Joffe F. CD44 mediates hyaluronan binding by human myeloid KG1A and KG1 cells. Blood. 83:1994;657-662.
76. Liu D., Sy M.S. A cysteine residue located in the transmembrane domain of CD44 is important in binding of CD44 to hyaluronic acid. J Exp Med. 183:1996;1987-1994.
77. Li R., Walker J.R., Johnson P. Chimeric CD4/CD44 molecules associate with CD44 via the transmembrane region and reduce hyaluronan binding in T cell lines. Eur J Immunol. 28:1998;1745-1754.
78. Haynes B.F., Telen M.J., Hale L.P., Denning S.M. CD44-a molecule involved in leukocyte adherence and T-cell activation [published erratum appears in Immunol Today (1990) 11(3):80]. Immunol Today. 10:1989;423-428.
79. Kansas G.S., Dailey M.O. Expression of adhesion structures during B cell development in man. J Immunol. 142:1989;3058-3062.
80. Murakami S., Miyake K., Kincade P.W., Hodes R.J. Functional role of CD44 (Pgp-1) on activated B cells. Immunol Res. 10:1991;15-27.
81. Murakami S., Miyake K., Abe R., Kincade P.W., Hodes R.J. Characterization of autoantibody-secreting B cells in mice undergoing stimulatory (chronic) graft-versus-host reactions. Identification of a CD. 44hi(population that binds specifically to hyaluronate. J Immunol 146):1991;1422-1427.
82. Kincade P.W. Cell interaction molecules and cytokines which participate in B lymphopoiesis. Baillieres Clin Haematol. 5:1992;575-598.
83. Camp R.L., Kraus T.A., Birkeland M.L., Pure E. High levels of CD44 expression distinguish virgin from antigen-primed B cells. J Exp Med. 173:1991;763-766.
84. Koshiishi I., Shizari M., Underhill C.B. CD44 can mediate the adhesion of platelets to hyaluronan. Blood. 84:1994;390-396.
85. Sandmaier B.M., Storb R., Appelbaum F.R., Gallatin W.M. An antibody that facilitates hematopoietic engraftment recognizes CD44. Blood. 76:1990;630-635.
86. Tan P.H., Santos E.B., Rossbach H.C., Sandmaier B.M. Enhancement of natural killer activity by an antibody to CD44. J Immunol. 150:1993;812-820.
87. Campanero M.R., Pulido R., Alonso J.L., Pivel J.P., Pimentel-Muinos F.X., Fresno M., Sanchez-Madrid F. Down-regulation by tumor necrosis factor-alpha of neutrophil cell surface expression of the sialophorin CD43 and the hyaluronate receptor CD44 through a proteolytic mechanism. Eur J Immunol. 21:1991;3045-3048.
88. Pericle F., Sconocchia G., Titus J.A., Segal D.M. CD44 is a cytotoxic triggering molecule on human polymorphonuclear cells. J Immunol. 157:1996;4657-4663.
89. Denning S.M., Le P.T., Singer K.H., Haynes B.F. Antibodies against the CD44 p80, lymphocyte homing receptor molecule augment human peripheral blood T cell activation. J Immunol. 144:1990;7-15.
90. Webb D.S., Shimizu Y., Van Seventer G.A., Shaw S., Gerrard T.L. LFA-3, CD44, and CD45. physiologic triggers of human monocyte TNF and IL-1 release Science. 249:1990;1295-1297.
91. Gruber M.F., Webb D.S., Gerrard T.L. Stimulation of human monocytes via CD45, CD44, and LFA-3 triggers macrophage-colony-stimulating factor production. Synergism with lipopolysaccharide and IL-. 1(beta. J Immunol 148):1992;1113-1118.
92. Noble P.W., Lake F.R., Henson P.M., Riches D.W. Hyaluronate activation of CD44 induces insulin-like growth factor-1 expression by a tumor necrosis factor-alpha-dependent mechanism in murine macrophages. J Clin Invest. 91:1993;2368-2377.
93. McKee C.M., Penno M.B., Cowman M., Burdick M.D., Strieter R.M., Bao C., Noble P.W. Hyaluronan (HA) fragments induce chemokine gene expression in alveolar macrophages. The role of HA size and CD. 44.(J Clin Invest 98):1996;2403-2413.
94. Rameshwar P., Chang V.T., Gascon P. Implication of CD44 in adhesion-mediated overproduction of TGF-beta and IL-1 in monocytes from patients with bone marrow fibrosis. Br J Haematol. 93:1996;22-29.
95. Trowbridge I.S., Lesley J., Schulte R., Hyman R., Trotter J. Biochemical characterization and cellular distribution of a polymorphic, murine cell-surface glycoprotein expressed on lymphoid tissues. Immunogenetics. 15:1982;299-312.
96. Hughes E.N., Colombatti A., August J.T. Murine cell surface glycoproteins. Purification of the polymorphic Pgp-1 antigen and analysis of its expression on macrophages and other myeloid cells. J Biol Chem. 258:1983;1014-1021.
97. Spangrude G.J., Klein J., Heimfeld S., Aihara Y., Weissman I.L. Two monoclonal antibodies identify thymic-repopulating cells in mouse bone marrow. J Immunol. 142:1989;425-430.
98. Lewinsohn D.M., Nagler A., Ginzton N., Greenberg P., Butcher E.C. Hematopoietic progenitor cell expression of the H-CAM (CD44) homing-associated adhesion molecule. Blood. 75:1990;589-595.
99. Kansas G.S., Muirhead M.J., Dailey M.O. Expression of the CD11/CD18, leukocyte adhesion molecule 1, and CD44 adhesion molecules during normal myeloid and erythroid differentiation in humans. Blood. 76:1990;2483-2492.
100. Ghaffari S., Dougherty G.J., Lansdorp P.M., Eaves A.C., Eaves C.J. Differentiation-associated changes in CD44 isoform expression during normal hematopoiesis and their alteration in chronic myeloid leukemia. Blood. 86:1995;2976-2985.
101. Ghaffari S., Dougherty G.J., Eaves A.C., Eaves C.J. Diverse effects of anti-CD44 antibodies on the stromal cell-mediated support of normal but not leukaemic (CML) haemopoiesis in vitro. Br J Haematol. 97:1997;22-28.
102. Gallagher J.T., Spooncer E., Dexter T.M. Role of the cellular matrix in haemopoiesis. I. Synthesis of glycosaminoglycans by mouse bone marrow cell cultures. J Cell Sci. 63:1983;155-171.
103. Spooncer E., Gallagher J.T., Krizsa F., Dexter T.M. Regulation of haemopoiesis in long-term bone marrow cultures. IV. Glycosaminoglycan synthesis and the stimulation of haemopoiesis by beta-D-xylosides. J Cell Biol. 96:1983;510-514.
104. Underhill C. CD44. the hyaluronan receptor J Cell Sci. 103:1992;293-298.
105. Smadja-Joffe F., Legras S., Girard N., Li Y., Delpech B., Bloget F., Morimoto K., Le Bousse-Kerdiles C., Clay D., Jasmin C., Levesque J.P. CD44 and hyaluronan binding by human myeloid cells. Leuk Lymphoma. 21:1996;407-520. (color plates following p. 528).
106. Ghaffari S., Dougherty G.J., Eaves A.C., Eaves C.J. Altered patterns of CD44 epitope expression in human chronic and acute myeloid leukemia. Leukemia. 10:1996;1773-1781.
107. Legras S., Levesque J.P., Charrad R., Morimoto K., Le Bousse C., Clay D., Jasmin C., Smadja-Joffe F. CD44-mediated adhesiveness of human hematopoietic progenitors to hyaluronan is modulated by cytokines. Blood. 89:1997;1905-1914.
108. Oostendorp R.A., Spitzer E., Dormer P. Adhesion of human hematopoietic progenitor cells to bone-marrow-derived stromal cells is enhanced by antibodies to CD44. Acta Haematologica. 95:1996;243-247.
109. Oostendorp R.A., Spitzer E., Brandl M., Eaves C.J., Dormer P. Evidence for differences in the mechanisms by which antibodies against CD44 promote adhesion of erythroid and granulopoietic progenitors to marrow stromal cells. Br J Haematol. 101:1998;436-445.
110. Oostendorp R.A., Spitzer E., Reisbach G., Dormer P. Antibodies to the beta 1-integrin chain, CD44, or ICAM-3 stimulate adhesion of blast colony-forming cells and may inhibit their growth. Exp Hematol. 25:1997;345-349.
111. Dittel B.N., Le Bien T.W. Reduced expression of vascular cell adhesion molecule-1 on bone marrow stromal cells isolated from marrow transplant recipients correlates with a reduced capacity to support human B lymphopoiesis in vitro. Blood. 86:1995;2833-2841.
112. + cells and acute myeloblastic but not lymphoblastic leukaemia cells to bone marrow stroma. Br J Haematol. 98:1997;828-837.
113. Rossbach H.C., Krizanac-Bengez L., Santos E.B., Gooley T.A., Sandmaier B.M. An antibody to CD44 enhances hematopoiesis in long-term marrow cultures. Exp Hematol. 24:1996;221-227.
114. Verfaillie C.M., Benis A., Iida J., McGlave P.B., McCarthy J.B. Adhesion of committed human hematopoietic progenitors to synthetic peptides from the C-terminal heparin-binding domain of fibronectin. cooperation between the integrin alpha 4 beta 1 and the CD44 adhesion receptor Blood. 84:1994;1802-1811.
115. + cells Blood. 80:1992;429-436.
116. Patel V.P., Lodish H.F. Loss of adhesion of murine erythroleukemia cells to fibronectin during erythroid differentiation. Science. 224:1984;996-998.
117. Sugahara H., Kanakura Y., Furitsu T., Ishihara K., Oritani K., Ikeda H., Kitayama H., Ishikawa J., Hashimoto K., Kanayama Y.et al. Induction of programmed cell death in human hematopoietic cell lines by fibronectin via its interaction with very late antigen 5. J Exp Med. 179:1994;1757-1766.
118. Tanaka Y., Adams D.H., Hubscher S., Hirano H., Siebenlist U., Shaw S. T-cell adhesion induced by proteoglycan-immobilized cytokine MIP-1 beta [see comments]. Nature. 361:1993;79-82.
119. Sandmaier B.M., Storb R., Liu Y., Santos E.B., Bryant E., Schuening F.G., Deeg H.J., Seidel K., Graham T. An anti-CD44 antibody does not enhance engraftment of DLA-identical marrow after low-dose total body irradiation. Transplant Immunol. 4:1996;271-274.
120. Vermeulen M., Le Pesteur F., Gagnerault M.C., Mary J.Y., Sainteny F., Lepault F. Role of adhesion molecules in the homing and mobilization of murine hematopoietic stem and progenitor cells. Blood. 92:1998;894-900.
121. Bennett K.L., Jackson D.G., Simon J.C., Tanczos E., Peach R., Modrell B., Stamenkovic I., Plowman G., Aruffo A. CD44 isoforms containing exon V3 are responsible for the presentation of heparin-binding growth factor. J Cell Biol. 128:1995;687-698.
122. Jackson D.G., Bell J.I., Dickinson R., Timans J., Shields J., Whittle N. Proteoglycan forms of the lymphocyte homing receptor CD44 are alternatively spliced variants containing the v3 exon. J Cell Biol. 128:1995;673-685.
123. Ruoslahti E. Proteoglycans in cell regulation. J Biol Chem. 264:1989;13369-13372.
124. Schlessinger J., Lax I., Lemmon M. Regulation of growth factor activation by proteoglycans. what is the role of the low affinity receptors? Cell. 83:1995;357-360.
125. Sherman L., Wainwright D., Ponta H., Herrlich P. A splice variant of CD44 expressed in the apical ectodermal ridge presents fibroblast growth factors to limb mesenchyme and is required for limb outgrowth. Genes Develop. 12:1998;1058-1071.
126. Gunthert U., Hofmann M., Rudy W., Reber S., Zoller M., Haussmann I., Matzku S., Wenzel A., Ponta H., Herrlich P. A new variant of glycoprotein CD44 confers metastatic potential to rat carcinoma cells. Cell. 65:1991;13-24.
127. Herrlich P., Zoller M., Pals S.T., Ponta H. CD44 splice variants. metastases meet lymphocytes Immunol Today. 14:1993;395-399.
128. Salles G., Zain M., Jiang W.M., Boussiotis V.A., Shipp M.A. Alternatively spliced CD44 transcripts in diffuse large-cell lymphomas. characterization and comparison with normal activated B cells and epithelial malignancies Blood. 82:1993;3539-3547.
129. Stauder R., Eisterer W., Thaler J., Gunthert U. CD44 variant isoforms in non-Hodgkin's lymphoma. a new independent prognostic factor Blood. 85:1995;2885-2899.
130. Stauder R., Van Driel M., Schwarzler C., Thaler J., Lokhorst H.M., Kreuser E.D., Bloem A.C., Gunthert U., Eisterer W. Different CD44 splicing patterns define prognostic subgroups in multiple myeloma. Blood. 88:1996;3101-3108.
131. Legras S., Gunthert U., Stauder R., Curt F., Oliferenko S., Kluin-Nelemans H.C., Marie J.P., Proctor S., Jasmin C., Smadja-Joffe F. A strong expression of CD44-6v correlates with shorter survival of patients with acute myeloid leukemia. Blood. 91:1998;3401-3413.
132. Arch R., Wirth K., Hofmann M., Ponta H., Matzku S., Herrlich P., Zoller M. Participation in normal immune responses of a metastasis-inducing splice variant of CD44 [see comments]. Science. 257:1992;682-685.
133. Koopman G., Heider K.H., Horst E., Adolf G.R., van den Berg F., Ponta H., Herrlich P., Pals S.T. Activated human lymphocytes and aggressive non-Hodgkin's lymphomas express a homologue of the rat metastasis-associated variant of CD44. J Exp Med. 177:1993;897-904.
134. Haegel H., Tolg C., Hofmann M., Ceredig R. Activated mouse astrocytes and T cells express similar CD44 variants. Role of CD. 44(in astrocyte/T cell binding. J Cell Biol 122):1993;1067-1077.
135. Mackay C.R., Terpe H.J., Stauder R., Marston W.L., Stark H., Gunthert U. Expression and modulation of CD44 variant isoforms in humans. J Cell Biol. 124:1994;71-82.
136. Patel D.D., Hale L.P., Whichard L.P., Radcliff G., Mackay C.R., Haynes B.F. Expression of CD44 molecules and CD44 ligands during human thymic fetal development. expression of CD44 isoforms is developmentally regulated Intl Immunol. 7:1995;277-286.
137. Wheatley S.C., Isacke C.M., Crossley P.H. Restricted expression of the hyaluronan receptor, CD44, during postimplantation mouse embryogenesis suggests key roles in tissue formation and patterning. Development. 119:1993;295-306.
138. Wirth K., Arch R., Somasundaram C., Hofmann M., Weber B., Herrlich P., Matzku S., Zoller M. Expression of CD44 isoforms carrying metastasis-associated sequences in newborn and adult rats. Eur J Cancer. 29:1993;1172-1177.
139. Terpe H.J., Stark H., Prehm P., Gunthert U. CD44 variant isoforms are preferentially expressed in basal epithelial of non-malignant human fetal and adult tissues. Histochemistry. 101:1994;79-89.
140. Campbell S., Swann H.R., Aplin J.D., Seif M.W., Kimber S.J., Elstein M. CD44 is expressed throughout pre-implantation human embryo development. Hum Reprod. 10:1995;425-430.
141. Zoller M., Schmidt A., Denzel A., Moll J. Constitutive expression of a CD44 variant isoform on T cells facilitates regaining of immunocompetence in allogeneic bone marrow transplantation. Blood. 90:1997;873-885.
142. Yu Q., Toole B.P., Stamenkovic I. Induction of apoptosis of metastatic mammary carcinoma cells in vivo by disruption of tumor cell surface CD44 function. J Exp Med. 186:1997;1985-1996.
143. Gunthert A.R., Strater J., von Reyher U., Henne C., Joos S., Koretz K., Moldenhauer G., Krammer P.H., Moller P. Early detachment of colon carcinoma cells during CD95(APO-1/Fas)-mediated apoptosis. I. De-adhesion from hyaluronate by shedding of CD44. J Cell Biol. 134:1996;1089-1096.
144. Wagner S.N., Wagner C., Reinhold U., Funk R., Zoller M., Goos M. Predominant expression of CD44 splice variant v10 in malignant and reactive human skin lymphocytes. J Invest Dermatol. 113:1998;464-471.
145. Pendergast A.M., Quilliam L.A., Cripe L.D., Bassing C.H., Dai Z., Li N., Batzer A., Rabun K.M., Der C.J., Schlessinger J.et al. BCR-ABL-induced oncogenesis is mediated by direct interaction with the SH2 domain of the GRB-2 adaptor protein. Cell. 75:1993;175-185.
146. Tauchi T., Boswell H.S., Leibowitz D., Broxmeyer H.E. Coupling between p210bcr-abl and Shc and Grb2 adaptor proteins in hematopoietic cells permits growth factor receptor-independent link to ras activation pathway. J Exp Med. 179:1994;167-175.
147. Hofmann M., Rudy W., Gunthert U., Zimmer S.G., Zawadzki V., Zoller M., Lichtner R.B., Herrlich P., Ponta H. A link between ras and metastatic behavior of tumor cells. ras induces CD44 promoter activity and leads to low-level expression of metastasis-specific variants of CD44 in CREF cells Cancer Res. 53:1993;1516-1521.
148. Jamal H.H., Cano-Gauci D.F., Buick R.N., Filmus J. Activated ras and src induce CD44 overexpression in rat intestinal epithelial cells. Oncogene. 9:1994;417-423.
149. Penno M.B., August J.T., Baylin S.B., Mabry M., Linnoila R.I., Lee V.S., Croteau D., Yang X.L., Rosada C. Expression of CD44 in human lung tumors. Cancer Res. 54:1994;1381-1387.
150. Gordon M.Y., Dowding C.R., Riley G.P., Goldman J.M., Greaves M.F. Altered adhesive interactions with marrow stroma of haematopoietic progenitor cells in chronic myeloid leukaemia. Nature. 328:1987;342-344.
151. Verfaillie C.M., McCarthy J.B., McGlave P.B. Mechanisms underlying abnormal trafficking of malignant progenitors in chronic myelogenous leukemia. Decreased adhesion to stroma and fibronectin but increased adhesion to the basement membrane components laminin and collagen type IV. J Clin Invest. 90:1992;1232-1241.
152. Bhatia R., Wayner E.A., McGlave P.B., Verfaillie C.M. Interferon-alpha restores normal adhesion of chronic myelogenous leukemia hematopoietic progenitors to bone marrow stroma by correcting impaired beta 1 integrin receptor function. J Clin Invest. 94:1994;384-391.
153. Lundell B.I., McCarthy J.B., Kovach N.L., Verfaillie C.M. Activation of beta1 integrins on CML progenitors reveals cooperation between beta1 integrins and CD44 in the regulation of adhesion and proliferation. Leukemia. 11:1997;822-829.
154. Gotoh A., Miyazawa K., Ohyashiki K., Tauchi T., Boswell H.S., Broxmeyer H.E., Toyama K. Tyrosine phosphorylation and activation of focal adhesion kinase (p125FAK) by BCR-ABL oncoprotein. Exp Hematol. 23:1995;1153-1159.
155. Salgia R., Brunkhorst B., Pisick E., Li J.L., Lo S.H., Chen L.B., Griffin J.D. Increased tyrosine phosphorylation of focal adhesion proteins in myeloid cell lines expressing p210BCR/ABL. Oncogene. 11:1995;1149-1155.
156. Salgia R., Li J.L., Lo S.H., Brunkhorst B., Kansas G.S., Sobhany E.S., Sun Y., Pisick E., Hallek M., Ernst T.et al. Molecular cloning of human paxillin, a focal adhesion protein phosphorylated by P210BCR/ABL. J Biol Chem. 270:1995;5039-5047.
157. Salgia R., Avraham S., Pisick E., Li J.L., Raja S., Greenfield E.A., Sattler M., Avraham H., Griffin J.D. The related adhesion focal tyrosine kinase forms a complex with paxillin in hematopoietic cells. J Biol Chem. 271:1996;31222-31226.
158. Salgia R., Sattler M., Pisick E., Li J.L., Griffin J.D. p210BCR/ABL induces formation of complexes containing focal adhesion proteins and the protooncogene product p120c-Cbl. Exp Hematol. 24:1996;310-313.
159. Salgia R., Li J.L., Ewaniuk D.S., Pear W., Pisick E., Burky S.A., Ernst T., Sattler M., Chen L.B., Griffin J.D. BCR/ABL induces multiple abnormalities
160. Wang J.Y., Ledley F., Goff S., Lee R., Groner Y., Baltimore D. The mouse c-abl locus. molecular cloning and characterization Cell. 36:1984;349-356.
161. Taagepera S., McDonald D., Loeb J.E., Whitaker L.L., McElroy A.K., Wang J.Y., Hope T.J. Nuclear-cytoplasmic shuttling of C-ABL tyrosine kinase. Proc Natl Acad Sci U S A. 95:1998;7457-7462.
162. McWhirter J.R., Wang J.Y. An actin-binding function contributes to transformation by the Bcr-Abl oncoprotein of Philadelphia chromosome-positive human leukemias. EMBO J. 12:1993;1533-1546.
163. Gumbiner B.M. Cell adhesion. the molecular basis of tissue architecture and morphogenesis Cell. 84:1996;345-357.
164. Craig S.W., Johnson R.P. Assembly of focal adhesions. progress, paradigms, and portents Curr Opin Cell Biol. 8:1996;74-85.
165. Lauffenburger D.A., Horwitz A.F. Cell migration. a physically integrated molecular process Cell. 84:1996;359-369.
166. Coso O.A., Chiariello M., Yu J.C., Teramoto H., Crespo P., Xu N., Miki T., Gutkind J.S. The small GTP-binding proteins Rac1 and Cdc42 regulate the activity of the JNK/SAPK signaling pathway. Cell. 81:1995;1137-1146.
167. Minden A., Lin A., Claret F.X., Abo A., Karin M. Selective activation of the JNK signaling cascade and c-Jun transcriptional activity by the small GTPases Rac and Cdc42Hs. Cell. 81:1995;1147-1157.
168. Bagrodia S., Derijard B., Davis R.J., Cerione R.A. Cdc42 and PAK-mediated signaling leads to Jun kinase and p38 mitogen-activated protein kinase activation. J Biol Chem. 270:1995;27995-27998.
169. Gupta S., Campbell D., Derijard B., Davis R.J. Transcription factor ATF2 regulation by the JNK signal transduction pathway. Science. 267:1995;389-393.
170. Ridley A.J., Paterson H.F., Johnston C.L., Diekmann D., Hall A. The small GTP-binding protein rac regulates growth factor-induced membrane ruffling. Cell. 70:1992;401-410.
171. Ridley A.J., Hall A. The small GTP-binding protein rho regulates the assembly of focal adhesions and actin stress fibers in response to growth factors. Cell. 70:1992;389-399.
172. Nobes C.D., Hall A. Rho, rac, and cdc42 GTPases regulate the assembly of multimolecular focal complexes associated with actin stress fibers, lamellipodia, and filopodia. Cell. 81:1995;53-62.
173. Zigmond S.H. Signal transduction and actin filament organization. Curr Opin Cell Biol. 8:1996;66-73.
174. Hotchin N.A., Hall A. The assembly of integrin adhesion complexes requires both extracellular matrix and intracellular rho/rac GTPases. J Cell Biol. 131:1995;1857-1865.
175. Hirao M., Sato N., Kondo T., Yonemura S., Monden M., Sasaki T., Takai Y., Tsukita S., Tsukita S. Regulation mechanism of ERM (ezrin/radixin/moesin) protein/plasma membrane association. possible involvement of phosphatidylinositol turnover and Rho-dependent signaling pathway J Cell Biol. 135:1996;37-51.
176. Yonemura S., Hirao M., Doi Y., Takahashi N., Kondo T., Tsukita S. Ezrin/radixin/moesin (ERM) proteins bind to a positively charged amino acid cluster in the juxta-membrane cytoplasmic domain of CD44, CD43, and ICAM-2. J Cell Biol. 140:1998;885-895.
177. Legg J.W., Isacke C.M. Identification and functional analysis of the ezrin-binding site in the hyaluronan receptor, CD44. Curr Biol. 8:1998;705-708.
178. Renshaw M.W., McWhirter J.R., Wang J.Y. The human leukemia oncogene bcr-abl abrogates the anchorage requirement but not the growth factor requirement for proliferation. Mol Cell Biol. 15:1995;1286-1293.
179. Skorski T., Wlodarski P., Daheron L., Salomoni P., Nieborowska-Skorska M., Majewski M., Wasik M., Calabretta B. BCR-ABL-mediated leukemogenesis requires the activity of the small GTP-binding protein Rac. PNAS. 95:1998;11858-11862.
180. Schmits R., Filmus J., Gerwin N., Senaldi G., Kiefer F., Kundig T., Wakeham A., Shahinian A., Catzavelos C., Rak J., Furlonger C., Zakarian A., Simard J.J., Ohashi P.S., Paige C.J., Gutierrez-Ramos J.C., Mak T.W. CD44 regulates hematopoietic progenitor distribution, granuloma formation, and tumorigenicity. Blood. 90:1997;2217-2233.
181. Khaldoyanidi S., Schnabel D., Fohr N., Zoller M. Functional activity of CD44 isoforms in haemopoiesis of the rat. Br J Haematol. 96:1997;31-45.
182. Oostendorp R.A., Eaves C.J. Quantitative analysis of the initial and CD44-independent phases of engraftment in a syngeneic marrow transplant model. Blood. 90:1997;402.
183. Pear W.S., Miller J.P., Xu L., Pui J.C., Soffer B., Quackenbush R.C., Pendergast A.M., Bronson R., Aster J.C., Scott M.L., Baltimore D. Efficient and rapid induction of a chronic myeloid leukemia-like myeloproliferative disease in mice receiving P210 bcr-abl-transduced bone marrow. Blood. 92:1998;3780-3792.
184. Zhang X., Ren R. Bcr-Abl efficiently induces a myeloproliferative disease and production of excess interleukin-3 and granulocyte-macrophage colony-stimulating factor in mice. a novel model for chronic myeloid leukemia Blood. 92:1998;3829-3840.